/ /

Clinical Pharmacology

Study: New cholesterol drugs cost 356 times more than genericsA report from the Alliance of Community Health Plans can help get a better sense of how well drugs help patients compared to other treatment options.
Four reasons why a hospital should open an integrated pharmacyWhen is retail right? Consider these four benefits that will impact the bottom line.
HHS makes clinical trials more transparentHHS finalized ClinicalTrial.gov rules encourage healthcare improvement and public benefit by increasing transparency and accountability across the industry.

Medicare Part D patients not taking blood pressure meds correctlyExpert offers specific actions for managed care execs to take
Integrated pharmacy model improves adherence, reduces costsStudy shows that an integrated pharmacy approach with community mental health centers produces higher adherence rates and lower overall healthcare costs.
Remicade will now have a biosimilarExpert: Expectations are high that biosimilars can control overall biologic cost growth.

Four things executives need to know to combat rising drug spendExecutives need to ask themselves four key questions to mitigate the negative impact of rising drug costs.
Biosimilar drugs appear comparable to brand-name counterpartsSystematic review provides comprehensive first look at TNF-alpha biosimilar treatments.
Increased utilization driving pharmacy spend in exchange plansExpress Scripts Exchange Pulse report found that utilization, particularly for traditional meds, was one of the biggest factors driving spending in 2015, accounting for more than half of the exchange plans $99 PMPY increase in spending between 2014 and 2015.
Antibiotic stewardship programs: 4 case studiesAll antibiotic use has the potential to contribute to the development of antibiotic resistance. That’s why it is key to reduce inappropriate antibiotic use in order to slow the growth of resistance.